Nov 30, 2018 7-9PM ET
Friday on The Robert Scott Bell Show – LIVE from Kissimee Fl – The SOHO Expo!
Special Guest – Dr. Mark Chaet!
Only 12 Percent of Adults Are Metabolically Healthy The prevalence of metabolic health in adults is ‘alarmingly low,’ in the U.S. even among people who are normal weight, a new study finds. Knowledge about metabolism has been increasing yet something is missing. Perhaps indirect advice on metabolism through old wisdom that kept hundreds of generations of people slender and strong. According to researchers at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health, only 1 in 8 Americans are achieving optimal metabolic health, which carries serious implications for public health. Poor metabolic health leaves people more vulnerable to developing Type 2 diabetes, cardiovascular disease and other serious health issues. The study presents the most updated United States data on metabolic health, which is defined as having optimal levels of five factors: blood glucose, triglycerides, high-density lipoprotein cholesterol, blood pressure and waist circumference, without the need for medications. For the study, researchers examined National Health and Nutrition Examination Survey data from 8,721 people in the U.S. between 2009 and 2016 to determine how many adults are at low versus high risk for chronic disease. Data revealed that only 12.2 percent of American adults are metabolically healthy, which means that only 27.3 million adults are meeting recommended targets for cardiovascular risk factors management, according to researchers.
When Clinical Trials Are Marketing Ploys, Not Science We all want to think our doctors find a way to keep up with the latest medical and pharmaceutical research. But what if that might lead to more off-label prescriptions that could be potentially harmful and expensive? Our current U.S. system for new pharmaceuticals and medical devices requires any company that creates a new treatment to gain approval from our regulatory agency, the Food & Drug Administration (FDA) before they are allowed to market and sell it. Ideally, they go through three phases of clinical trials: Phase I assesses safety, Phase II tests efficacy, and Phase III studies the effects of the drug in randomized and blind tests of large numbers of patients (ideally hundreds or thousands). But increasingly, companies have found ways to either getout of or water down Phase III trials, resulting in a lot of unconfirmed information about the drugs we’re prescribed. There are, of course, many thousands of Phase III clinical trials in progress, but being able to bring a drug to market without their satisfactory completion is becoming increasingly common, despite plenty of evidencethat the drugs can still be shown to be ineffective or harmful at this stage.
Government dietary guidelines are plain wrong: Avoid carbs, not fat America is facing a chronic disease crisis. The federal government is fueling that crisis by promoting flawed nutritional advice that contradicts the latest research. Every five years, the Departments of Agriculture and Health and Human Services publish the “Dietary Guidelines for Americans,” which detail which foods Americans should eat or avoid. The highly influential document directs food labeling, school menus, public food programs, and government research grants. Researchers claim the guidelines are based on “the preponderance of current scientific and medical knowledge.” Yet, since they were first introduced back in 1980, they’ve barely changed, even though a recent revolution in nutritional science has cast doubt on old assumptions. Federal officials just started work on the 2020 edition. It is imperative that they take all the latest research into account.
Harvard study: Children who start school early more likely to get ADHD diagnosis — even if they don’t haveit Harvard University researchers have found that children who start school up to a year sooner than many of their peers are more likely to be diagnosed with ADHD — even if they don’t really have the condition. As a result, large numbers of children may be improperly labeled with the disorder when, instead, they are just immature. In a study published in the New England Journal of Medicine, the researchers looked at the records of more than 407,000 children from every state and found that younger children in the same grouping of students had a 30 percent higher risk for an ADHD diagnosis than older students. It said this variation may be explained by experts labeling children as having attention-deficit/hyperactivity disorder when they are simply displaying behavior consistent with their age.
Special Guest Maggie Frank – CV Sciences
With over 10 years in the Natural Products Industry, Maggie Frank has cultivated her passion for education through her extensive experience as an educator and health and wellness advocate. Ms. Frank first found her passion for nutrition while living on a sailboat in Mexico. Having to catch fish and trade for fresh fruits and vegetables, Ms. Frank came to the realization that whole, fresh foods make for a healthy, happy and and more balanced lifestyle. Inspired and determined, she then set off to share this experience with others and educate the public about nutrition. Ms. Frank started in the industry with a part-time job at Henry’s Marketplace (now known as Sprouts) in Carlsbad,CA and worked her way up to Natural Living Manager. She then graduated to National Educator for the esteemed greens company, Vibrant Health. She currently serves as the National Educator for CV Sciences, and believes hemp and phytocannabinoids hold tremendous promise for human health.
Multiple Studies Show Using CBD Oil for Sleep Disorders May Be Your Safest Bet We all need an adequate amount of sleep to stay healthy, energetic, and mentally acute. Yet, many factors can easily get in the way of that ideal 7 to 8 hours of sleep per night. Stress, a troubled mind, physical discomfort, and countless other factors can cause you to lose out on sleep. This is where cannabidiol (CBD) can be a crucial supplement. First, let’s look at your options when it comes to pharmaceutical sleeping aides. There are some seemingly-innocuous over-the-counter (OTC) medications, such as Tylenol PM, Benadryl and Unisom. Most of these have typical OTC drug side-effects, such as dry mouth, blurred vision and constipation. Unfortunately, many sufferers don’t realize that these OTC drugs are meant to be taken on a short-term basis. Long-term use can compromise the body on a more biological level, causing problems such as liver toxicity. Furthermore, many of these OTC sleep aides may cause daytime drowsiness. Doesn’t this actually defeat the reason why you would want to use them? If you’re taking drugs to get some sleep, you’d hope to have energy the next day, versus still feeling sluggish.
Special Guest – Stuart Tomc!
Stuart Tomc serves as a Vice President of Human Nutrition at CV Sciences, Inc. Mr. Tomc served as Head of Product Development at CannaVEST Corp. He is a recognized authority on dietary supplements, with twenty years of experience in the nutritional health industry. He served as Vice President of North American Herb and Spice, where he served for 10 years, in addition to his service as Global Educator for omega-3 market leader, Nordic Naturals, Mr. Tomc is known for
Study: CBD May Provide Pain And Anxiety Relief In Different Ways Than Previously Thought An animal study has identified new pathways by which cannabidiol (CBD), the non-intoxicating compound in marijuana, affects the brain and nervous system without getting users high. If replicable in humans, the finding may strengthen the argument that a moderate dose of CBD could be a safer alternative to standard pain and anxiety meds for many patients. While excitement continues to build around CBD’s therapeutic potential, research showing the drug’s mechanism of action is still quite thin. Most attempts have focused on the endocannabinoid system, home of the CB1 cannabinoid receptors that marijuana’s psychoactive compound, tetrahydrocannabinol (THC), binds to, resulting in the euphoria associated with the drug. But the latest study shows that CBD acts on different receptors to deliver pain and anxiety relief without euphoria. Specifically, the findings point to interaction with serotonin (5 HT) receptors that are central to the management of anxiety, and vanilloid (TRPV1) receptors, a target for non-addictive forms of pain relief.
CBD is about to revolutionize the veteran community and PTSD, taking America by storm CBD is the latest product taking the United States by storm, and chances are you’ve probably already heard about the hemp-derived chemical compound by now. The CBD market has grown so much that it has drawn in everyone from U.S. senators to multi-billion-dollar companies – and the veteran community, where it already has a huge following of vets who use the product to help with PTSD. Even Coca-Cola, the world’s largest soda company, released a statement earlier this year saying it is closely watching the growth of CBD “as an ingredient in functional wellness beverages around the world,” leading to speculation of a future CBD-infused drink. The CBD market is expected to grow to $22 billion by 2022 – an astronomical growth compared to its expected $591 million this year. Many people already swear by CBD’s pain-relieving, anxiety-relieving properties, delivered without a “high” or any psychoactive effects on body functions. There are veterans who say it has helped them deal with anxiety and PTSD more than anything they can get prescribed by the VA or a doctor.
Special Guest – Josh Hendrix!
Born and raised in the Bluegrass State and a University of Kentucky alumnus, Mr. Hendrix relocated back to Central Kentucky in 2014 on a mission to help rebuild the US hemp industry. Seeing a need to bring farmers, processors, manufacturers and supporters of the industry together, Mr. Hendrix founded the Kentucky Hemp Industries Association that summer and still serves on the Board of Directors. He also became an active member of the Kentucky Hemp Industries Council where he now serves as Treasurer on the Board of Directors. In 2015 he created and became President of Hendrix Hemp, a licensed hemp producer that manages hemp cultivation on his family’s, Mayflower Farm, in Mount Sterling, KY. In early 2016 Mr. Hendrix was appointed to the Technical Advisory Council for the National Hemp Association and accepted a role on the Senior Advisory Board of the institutional trading platform for hemp, Seed CX. Currently Mr. Hendrix serves as the Director of Business Development – Domestic Production for CV Sciences, Inc. where he works with numerous universities, farmers, businesses, and organizations to help facilitate the infrastructure necessary to establish a modern domestic supply chain for hemp in the United States.
The truth about supplements: do they work and should you take them? FOR some people, they are an insurance policy against a less-than-perfect diet. Others take them because they can’t – or won’t – eat certain foods. Whatever the reasons, popping vitamin and mineral supplements can feel like a virtuous shortcut to a healthy life. But in recent months, serious doubts have been raised over whether they are actually any good for us. Take omega-3. For many people, these golden capsules are a way to get the essential fatty acids we are told our bodies need without having to consume oily fish. Yet recent studies indicate that – unlike eating fish – taking omega-3 or fish oil supplements does nothing to reduce your risk of heart disease, stroke or early death. It is a similar story for other nutritional supplements, including multivitamins: the results from a slew of studies on their impact on our health has been underwhelming. In some cases, taking high doses of certain nutrients may even be harmful. We are also waking up to the importance of the interactions between the different foods we eat and how these influence the uptake of the nutrients they contain. It turns out it’s not what we eat, it’s how we eat it.
Special Guest Miles Sarill!
Passionate about natural wellness from a young age, Miles received his Master’s in Experimental Medicine from McGill University.
Remember Friends, The Power to Heal is Yours!
More upcoming RSB events:
- SOHO EXPO Nov 29-Dec 2, 2018 KISSIMMEE, FL
- Total Health ’19 Toronto Canada April 12-14, 2019!
- Advanced Medicine Conference May 25-26, 2019 Los Angeles, CA